Glycine transporter inhibitors: A new avenue for managing neuropathic pain M Al-Khrasani, A Mohammadzadeh, M Balogh, K Király, S Barsi, B Hajnal, ... Brain Research Bulletin 152, 143-158, 2019 | 35 | 2019 |
Pharmacological evidence on augmented antiallodynia following systemic co-treatment with GlyT-1 and GlyT-2 inhibitors in rat neuropathic pain model A Mohammadzadeh, PP Lakatos, M Balogh, F Zádor, DÁ Karádi, ... International Journal of Molecular Sciences 22 (5), 2479, 2021 | 15 | 2021 |
Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate F Zádor, A Mohammadzadeh, M Balogh, ZS Zádori, K Király, S Barsi, ... Molecules 25 (6), 1370, 2020 | 12 | 2020 |
Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity S Barsi, H Papp, A Valdeolivas, DJ Tóth, A Kuczmog, M Madai, ... PLoS computational biology 18 (4), e1010021, 2022 | 8 | 2022 |
Modeling in systems biology: Causal understanding before prediction? S Barsi, B Szalai Patterns 2 (6), 100280, 2021 | 4 | 2021 |
An unexpected enzyme in vascular smooth muscle cells: angiotensin II upregulates cholesterol-25-hydroxylase gene expression KB Kovács, L Szalai, P Szabó, JB Gém, S Barsi, B Szalai, B Perey-Simon, ... International Journal of Molecular Sciences 24 (4), 3968, 2023 | 2 | 2023 |
Tri-Lineage Differentiation of NTERA2 Clone D1 Cells towards Neural, Hepatic and Osteogenic Lineages in Vitro B Szeky, B Mayer, M Gyongy, A Hajdara, S Barsi, S Karpati, K Nemeth Folia Biologica (Praha) 67, 174-182, 2021 | | 2021 |